BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26489728)

  • 1. Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
    Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
    Thromb Res; 2015 Dec; 136(6):1245-51. PubMed ID: 26489728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis.
    Tomizawa A; Ohno K; Jakubowski JA; Mizuno M; Sugidachi A
    Thromb Res; 2015 Dec; 136(6):1224-30. PubMed ID: 26388120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation triggers both c-Jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK) activation and neointimal hyperplasia induced by cessation of blood flow in the mouse carotid artery.
    Squadrito F; Minutoli L; Esposito M; Bitto A; Marini H; Seminara P; Crisafulli A; Passaniti M; Adamo EB; Marini R; Guarini S; Altavilla D
    Atherosclerosis; 2005 Feb; 178(2):295-302. PubMed ID: 15694937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
    Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
    Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2018 Jul; 46(1):95-101. PubMed ID: 29704172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the P2Y12 antagonist ticagrelor on neointimal hyperplasia in a rabbit carotid anastomosis model†.
    Sürer S; Toktas F; Ay D; Eris C; Yavuz S; Turk T; Vural AH; Goncu MT; Gul NY; Yalcınkaya U
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):198-204. PubMed ID: 24876217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel.
    Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
    Thromb Res; 2015 May; 135(5):933-8. PubMed ID: 25776467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
    Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow.
    Squadrito F; Deodato B; Bova A; Marini H; Saporito F; Calò M; Giacca M; Minutoli L; Venuti FS; Caputi AP; Altavilla D
    Atherosclerosis; 2003 Feb; 166(2):233-42. PubMed ID: 12535735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.
    Kanellakis P; Pomilio G; Walker C; Husband A; Huang JL; Nestel P; Agrotis A; Bobik A
    Atherosclerosis; 2009 May; 204(1):66-72. PubMed ID: 18930230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
    Nishihira K; Yamashita A; Tanaka N; Kawamoto R; Imamura T; Yamamoto R; Eto T; Asada Y
    J Thromb Haemost; 2006 Jan; 4(1):247-55. PubMed ID: 16409475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
    Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal hyperplasia occurring after carotid endarterectomy in a canine model: effect of endothelial cell seeding vs. perioperative aspirin.
    Bush HL; Jakubowski JA; Sentissi JM; Curl GR; Hayes JA; Deykin D
    J Vasc Surg; 1987 Jan; 5(1):118-25. PubMed ID: 3795378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transfer of human placental ectonucleoside triphosphate diphosphohydrolase to vascular smooth muscle cells suppresses platelet aggregation in vitro and arterial thrombus formation in vivo.
    Furukoji E; Matsumoto M; Yamashita A; Yagi H; Sakurai Y; Marutsuka K; Hatakeyama K; Morishita K; Fujimura Y; Tamura S; Asada Y
    Circulation; 2005 Feb; 111(6):808-15. PubMed ID: 15699260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
    Moon MC; Molnar K; Yau L; Zahradka P
    J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.
    Furukawa Y; Matsumori A; Ohashi N; Shioi T; Ono K; Harada A; Matsushima K; Sasayama S
    Circ Res; 1999 Feb; 84(3):306-14. PubMed ID: 10024304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.